{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:13:09Z","timestamp":1791245589845,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Technology Plan Project of Tangshan","award":["22130222G"],"award-info":[{"award-number":["22130222G"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12072-025-10939-8","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:32:14Z","timestamp":1761395534000},"page":"303-319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["p53 regulates glucose metabolic reprogramming in MASLD-related hepatocellular carcinoma via modulating mitochondrial pyruvate carriers"],"prefix":"10.1007","volume":"20","author":[{"given":"Ze","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiufang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zechao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"issue":"4","key":"10939_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/1744666X.2023.2294046","volume":"20","author":"J Schw\u00e4rzler","year":"2024","unstructured":"Schw\u00e4rzler J, Grabherr F, Grander C, Adolph TE, Tilg H. The pathophysiology of MASLD: an immunometabolic perspective. Expert Rev Clin Immunol. 2024;20(4):375\u2013386","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"10939_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","volume":"15","author":"VW Wong","year":"2018","unstructured":"Wong VW, Adams LA, de L\u00e9dinghen V, Wong GL, Sookoian S. Noninvasive biomarkers in NAFLD and NASH \u2013 current progress and future promise. Nat Rev Gastroenterol Hepatol. 2018;15(8):461\u2013478","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10939_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.103910","volume":"29","author":"S Wei","year":"2024","unstructured":"Wei S, Wang L, Evans PC, Xu S. NAFLD and NASH: etiology, targets and emerging therapies. Drug Discov Today. 2024;29(3):103910","journal-title":"Drug Discov Today"},{"issue":"6","key":"10939_CR4","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","volume":"79","author":"AL Hutchison","year":"2023","unstructured":"Hutchison AL, Tavaglione F, Romeo S, Charlton M. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance. J Hepatol. 2023;79(6):1524\u20131541","journal-title":"J Hepatol"},{"issue":"8","key":"10939_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","volume":"18","author":"E Barreby","year":"2022","unstructured":"Barreby E, Chen P, Aouadi M. Macrophage functional diversity in NAFLD \u2013 more than inflammation. Nat Rev Endocrinol. 2022;18(8):461\u2013472","journal-title":"Nat Rev Endocrinol"},{"key":"10939_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101889","volume":"81","author":"G Villano","year":"2024","unstructured":"Villano G, Novo E, Turato C, Quarta S, Ruvoletto M, Biasiolo A, et al. The protease activated receptor 2 \u2013 CCAAT\/enhancer-binding protein beta \u2013 SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis. Mol Metab. 2024;81: 101889","journal-title":"Mol Metab"},{"key":"10939_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101789","volume":"76","author":"Z Bai","year":"2023","unstructured":"Bai Z, Yin W, Liu R, Tang M, Shi X, Luo C, et al. PRDX1 Cys52Ser variant alleviates nonalcoholic steatohepatitis by reducing inflammation in mice. Mol Metab. 2023;76:101789","journal-title":"Mol Metab"},{"issue":"3","key":"10939_CR8","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10939_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cell.2007.08.005","volume":"130","author":"Y Aylon","year":"2007","unstructured":"Aylon Y, Oren M. Living with p53, dying of p53. Cell. 2007;130(4):597\u2013600","journal-title":"Cell"},{"issue":"10","key":"10939_CR10","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc2716","volume":"9","author":"DW Meek","year":"2009","unstructured":"Meek DW. Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer. 2009;9(10):714\u2013723","journal-title":"Nat Rev Cancer"},{"issue":"6090","key":"10939_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.1218530","volume":"337","author":"S Herzig","year":"2012","unstructured":"Herzig S, Raemy E, Montessuit S, Veuthey JL, Zamboni N, Westermann B, et al. Identification and functional expression of the mitochondrial pyruvate carrier. Science. 2012;337(6090):93\u201396","journal-title":"Science"},{"issue":"2","key":"10939_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ccell.2018.12.012","volume":"35","author":"J Kim","year":"2019","unstructured":"Kim J, Yu L, Chen W, Xu Y, Wu M, Todorova D, et al. Wild-type p53 promotes cancer metabolic switch by inducing PUMA-dependent suppression of oxidative phosphorylation. Cancer Cell. 2019;35(2):191\u2013203.e8","journal-title":"Cancer Cell"},{"issue":"1","key":"10939_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cmet.2014.05.001","volume":"20","author":"A Umemura","year":"2014","unstructured":"Umemura A, Park EJ, Taniguchi K, Lee JH, Shalapour S, Valasek MA, et al. Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. Cell Metab. 2014;20(1):133\u2013144","journal-title":"Cell Metab"},{"issue":"4","key":"10939_CR14","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.32731","volume":"77","author":"D Loureiro","year":"2023","unstructured":"Loureiro D, Tout I, Narguet S, Bed CM, Roinard M, Sleiman A, et al. Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis. Hepatology. 2023;77(4):1348\u20131365","journal-title":"Hepatology"},{"issue":"1","key":"10939_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41392-023-01437-0","volume":"8","author":"B Ma","year":"2023","unstructured":"Ma B, Ju A, Zhang S, An Q, Xu S, Liu J, et al. Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease. Signal Transduct Target Ther. 2023;8(1):229","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10939_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","volume":"155","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T. Mitochondrial dysfunction and signaling in chronic liver diseases. Gastroenterology. 2018;155(3):629\u2013647","journal-title":"Gastroenterology"},{"issue":"1","key":"10939_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12967-022-03540-2","volume":"20","author":"R Li","year":"2022","unstructured":"Li R, Li Y, Yang X, Hu Y, Yu H, Li Y. Reducing VEGFB accelerates NAFLD and insulin resistance in mice via inhibiting AMPK signaling pathway. J Transl Med. 2022;20(1):341","journal-title":"J Transl Med"},{"key":"10939_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26051879","author":"W Andryszkiewicz","year":"2025","unstructured":"Andryszkiewicz W, G\u0105siorowska J, K\u00fcbler M, Kubli\u0144ska K, Pa\u0142kiewicz A, Wiatkowski A, et al. Glucose metabolism and tumor microenvironment: mechanistic insights and therapeutic implications. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26051879","journal-title":"Int J Mol Sci"},{"key":"10939_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.semcancer.2025.03.006","volume":"112","author":"H Jiang","year":"2025","unstructured":"Jiang H, Ye J. The warburg effect: the hacked mitochondrial-nuclear communication in cancer. Semin Cancer Biol. 2025;112:93\u2013111","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10939_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","volume":"126","author":"K Bensaad","year":"2006","unstructured":"Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell. 2006;126(1):107\u2013120","journal-title":"Cell"},{"issue":"23","key":"10939_CR21","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.15252\/embj.201696239","volume":"36","author":"MR Khan","year":"2017","unstructured":"Khan MR, Xiang S, Song Z, Wu M. The p53-inducible long noncoding RNA TRINGS protects cancer cells from necrosis under glucose starvation. EMBO J. 2017;36(23):3483\u20133500","journal-title":"EMBO J"},{"issue":"7","key":"10939_CR22","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.celrep.2015.01.043","volume":"10","author":"D Jiang","year":"2015","unstructured":"Jiang D, LaGory EL, Kenzelmann Bro\u017e D, Bieging KT, Brady CA, Link N, et al. Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function. Cell Rep. 2015;10(7):1096\u20131109","journal-title":"Cell Rep"},{"issue":"10","key":"10939_CR23","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.bbalip.2018.07.011","volume":"1863","author":"S Brachtendorf","year":"2018","unstructured":"Brachtendorf S, Wanger RA, Birod K, Thomas D, Trautmann S, Wegner MS, et al. Chemosensitivity of human colon cancer cells is influenced by a p53-dependent enhancement of ceramide synthase 5 and induction of autophagy. Biochim Biophys Acta. 2018;1863(10):1214\u20131227","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10939_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/cdd.2012.168","volume":"20","author":"N Sanchez-Macedo","year":"2013","unstructured":"Sanchez-Macedo N, Feng J, Faubert B, Chang N, Elia A, Rushing EJ, et al. Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model. Cell Death Differ. 2013;20(4):659\u2013668","journal-title":"Cell Death Differ"},{"issue":"6","key":"10939_CR25","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1158\/2159-8290.CD-14-0921","volume":"5","author":"JL Van Nostrand","year":"2015","unstructured":"Van Nostrand JL, Brisac A, Mello SS, Jacobs SB, Luong R, Attardi LD. The p53 target gene SIVA enables non-small cell lung cancer development. Cancer Discov. 2015;5(6):622\u2013635","journal-title":"Cancer Discov"},{"key":"10939_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.010","volume":"85","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gu W. The complexity of p53-mediated metabolic regulation in tumor suppression. Semin Cancer Biol. 2022;85:4\u201332","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10939_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrclinonc.2017.151","volume":"15","author":"K Sabapathy","year":"2018","unstructured":"Sabapathy K, Lane DP. Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others. Nat Rev Clin Oncol. 2018;15(1):13\u201330","journal-title":"Nat Rev Clin Oncol"},{"key":"10939_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semcancer.2020.07.005","volume":"79","author":"MJ Duffy","year":"2022","unstructured":"Duffy MJ, Synnott NC, O\u2019Grady S, Crown J. Targeting p53 for the treatment of cancer. Semin Cancer Biol. 2022;79:58\u201367","journal-title":"Semin Cancer Biol"},{"key":"10939_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217614","volume":"617","author":"HH Wu","year":"2025","unstructured":"Wu HH, Leng S, Eisenstat DD, Sergi C, Leng R. Targeting p53 for immune modulation: exploring its functions in tumor immunity and inflammation. Cancer Lett. 2025;617:217614","journal-title":"Cancer Lett"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10939-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-10939-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10939-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T18:29:28Z","timestamp":1777314568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-10939-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10939"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-10939-8","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}